The DOI matches its Crossref record; 174 of the 174 references it cites were found in a registry or an index.
Immunotherapeutic applications of CpG oligodeoxynucleotide TLR9 agonists
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: DNA-PKcs Is Required for Activation of Innate Immunity by Immunostimulatory DNA
Chu, W.-M., Gong, X., Li, Z.-W., Takabayashi, K., Ouyang, H.-H., Chen, Y., Lois, A., Chen, D. J., Li, G. C., Karin, M., et al. (2000) · Cell · doi:10.1016/s0092-8674(00)00194-x · Cited by 178
RetractedA Toll-like receptor recognizes bacterial DNA
Hemmi, H., Takeuchi, O., Kawai, T., Kaisho, T., Sato, S., Sanjo, H., Matsumoto, M., Hoshino, K., Wagner, H., Takeda, K., et al. (2000) · Nature · doi:10.1038/35047123 · Cited by 6,491
Toll-like receptor control of the adaptive immune responses
Iwasaki, A., & Medzhitov, R. (2004) · Nature Immunology · doi:10.1038/ni1112 · Cited by 4,193
Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8
Heil, F., Hemmi, H., Hochrein, H., Ampenberger, F., Kirschning, C., Akira, S., Lipford, G., Wagner, H., & Bauer, S. (2004) · Science · doi:10.1126/science.1093620 · Cited by 3,947
CpG motifs in bacterial DNA trigger direct B-cell activation
Krieg, A. M., Yi, A.-K., Matson, S., Waldschmidt, T. J., Bishop, G. A., Teasdale, R., Koretzky, G. A., & Klinman, D. M. (1995) · Nature · doi:10.1038/374546a0 · Cited by 3,508
Self-citationInnate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA
Diebold, S. S., Kaisho, T., Hemmi, H., Akira, S., & Reis e Sousa, C. (2004) · Science · doi:10.1126/science.1093616 · Cited by 3,444
Cancer immunotherapy: moving beyond current vaccines
Rosenberg, S. A., Yang, J. C., & Restifo, N. P. (2004) · Nature Medicine · doi:10.1038/nm1100 · Cited by 2,972
Recognition of microorganisms and activation of the immune response
Medzhitov, R. (2007) · Nature · doi:10.1038/nature06246 · Cited by 2,862
CpG Motifs in Bacterial DNA and Their Immune Effects
Krieg, A. M. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.100301.064842 · Cited by 2,573
Self-citationHuman TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition
Bauer, S., Kirschning, C. J., Häcker, H., Redecke, V., Hausmann, S., Akira, S., Wagner, H., & Lipford, G. B. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.161293498 · Cited by 1,533
TLR9 signals after translocating from the ER to CpG DNA in the lysosome
Latz, E., Schoenemeyer, A., Visintin, A., Fitzgerald, K. A., Monks, B. G., Knetter, C. F., Lien, E., Nilsen, N. J., Espevik, T., & Golenbock, D. T. (2004) · Nature Immunology · doi:10.1038/ni1028 · Cited by 1,361
IRAK-M Is a Negative Regulator of Toll-like Receptor Signaling
Kobayashi, K., Hernandez, L. D., Galán, J. E., Janeway, C. A., Medzhitov, R., & Flavell, R. A. (2002) · Cell · doi:10.1016/s0092-8674(02)00827-9 · Cited by 1,286
Toll-Like Receptor Signaling Pathways
Barton, G. M., & Medzhitov, R. (2003) · Science · doi:10.1126/science.1085536 · Cited by 1,265
Kawai, T., Sato, S., Ishii, K. J., Coban, C., Hemmi, H., Yamamoto, M., Terai, K., Matsuda, M., Inoue, J.-I., Uematsu, S., et al. (2004) · Nature Immunology · doi:10.1038/ni1118 · Cited by 1,033
Immunotherapeutic uses of CpG oligodeoxynucleotides
Klinman, D. M. (2004) · Nature Reviews Immunology · doi:10.1038/nri1329 · Cited by 1,012
CpG Oligodeoxynucleotides Act as Adjuvants that Switch on T Helper 1 (Th1) Immunity
Chu, R. S., Targoni, O. S., Krieg, A. M., Lehmann, P. V., & Harding, C. V. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.10.1623 · Cited by 1,002
Self-citationToll-like receptors stimulate human neutrophil function
Hayashi, F., Means, T. K., & Luster, A. D. (2003) · Blood · doi:10.1182/blood-2003-04-1078 · Cited by 939
Barrat, F. J., Meeker, T., Gregorio, J., Chan, J. H., Uematsu, S., Akira, S., Chang, B., Duramad, O., & Coffman, R. L. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050914 · Cited by 928
Spatiotemporal regulation of MyD88–IRF-7 signalling for robust type-I interferon induction
Honda, K., Ohba, Y., Yanai, H., Negishi, H., Mizutani, T., Takaoka, A., Taya, C., & Taniguchi, T. (2005) · Nature · doi:10.1038/nature03547 · Cited by 912
Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants
Roman, M., Martin-Orozco, E., Goodman, J. S., Nguyen, M.-D., Sato, Y., Ronaghy, A., Kornbluth, R. S., Richman, D. D., Carson, D. A., & Raz, E. (1997) · Nature Medicine · doi:10.1038/nm0897-849 · Cited by 908
Krug, A., Rothenfusser, S., Hornung, V., Jahrsdörfer, B., Blackwell, S., Ballas, Z. K., Endres, S., Krieg, A. M., & Hartmann, G. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(200107)31:7<2154::aid-immu2154>3.0.co;2-u · Cited by 882
Self-citationHuman lupus autoantibody–DNA complexes activate DCs through cooperation of CD32 and TLR9
Means, T. K., Latz, E., Hayashi, F., Murali, M. R., Golenbock, D. T., & Luster, A. D. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200523025 · Cited by 849
Herrmann, M., Voll, R. E., Zoller, O. M., Hagenhofer, M., Ponner, B. B., & Kalden, J. R. (1998) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199807)41:7<1241::aid-art15>3.0.co;2-h · Cited by 839
Lau, C. M., Broughton, C., Tabor, A. S., Akira, S., Flavell, R. A., Mamula, M. J., Christensen, S. R., Shlomchik, M. J., Viglianti, G. A., Rifkin, I. R., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050630 · Cited by 812
Leucine-rich repeats and pathogen recognition in Toll-like receptors
Bell, J. K., Mullen, G. E. D., Leifer, C. A., Mazzoni, A., Davies, D. R., & Segal, D. M. (2003) · Trends in Immunology · doi:10.1016/s1471-4906(03)00242-4 · Cited by 762
Ballas, Z. K., Rasmussen, W. L., & Krieg, A. M. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.5.1840 · Cited by 754
Self-citationStructural Basis of Toll-Like Receptor 3 Signaling with Double-Stranded RNA
Liu, L., Botos, I., Wang, Y., Leonard, J. N., Shiloach, J., Segal, D. M., & Davies, D. R. (2008) · Science · doi:10.1126/science.1155406 · Cited by 733
Ahmad-Nejad, P., Häcker, H., Rutz, M., Bauer, S., Vabulas, R. M., & Wagner, H. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(200207)32:7<1958::aid-immu1958>3.0.co;2-u · Cited by 717
Davis, H. L., Weeranta, R., Waldschmidt, T. J., Tygrett, L., Schorr, J., & Krieg, A. M. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.2.870 · Cited by 677
Self-citationBarton, G. M., Kagan, J. C., & Medzhitov, R. (2006) · Nature Immunology · doi:10.1038/ni1280 · Cited by 670
Immunotherapy and chemotherapy — a practical partnership
Lake, R. A., & Robinson, B. W. S. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1613 · Cited by 646
UNC93B1 delivers nucleotide-sensing toll-like receptors to endolysosomes
Kim, Y.-M., Brinkmann, M. M., Paquet, M.-E., & Ploegh, H. L. (2008) · Nature · doi:10.1038/nature06726 · Cited by 645
Speiser, D. E., Líénard, D., Rufer, N., Rubio‐Godoy, V., Rimoldi, D., Lejeune, F. J., Krieg, A. Μ., Cerottini, J., & Romero, P. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200523373 · Cited by 640
Self-citationSIGIRR, a negative regulator of Toll-like receptor–interleukin 1 receptor signaling
Wald, D., Qin, J., Zhao, Z., Qian, Y., Naramura, M., Tian, L., Towne, J., Sims, J. E., Stark, G. R., & Li, X. (2003) · Nature Immunology · doi:10.1038/ni968 · Cited by 606
Mechanism and Function of a Newly Identified CpG DNA Motif in Human Primary B Cells
Hartmann, G., & Krieg, A. M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.2.944 · Cited by 605
Self-citationCrystal Structure of Human Toll-Like Receptor 3 (TLR3) Ectodomain
Choe, J., Kelker, M. S., & Wilson, I. A. (2005) · Science · doi:10.1126/science.1115253 · Cited by 602
Vollmer, J., Weeratna, R., Payette, P., Jurk, M., Schetter, C., Laucht, M., Wader, T., Tluk, S., Liu, M., Davis, H. L., et al. (2004) · European Journal of Immunology · doi:10.1002/eji.200324032 · Cited by 595
Self-citationHartmann, G., Weeratna, R. D., Ballas, Z. K., Payette, P., Blackwell, S., Suparto, I., Rasmussen, W. L., Waldschmidt, M., Sajuthi, D., Purcell, R. H., et al. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.3.1617 · Cited by 585
Self-citationMuzio, M., Natoli, G., Saccani, S., Levrero, M., & Mantovani, A. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.12.2097 · Cited by 574
Modulation of airway inflammation by CpG oligodeoxynucleotides in a murine model of asthma.
Kline, J. N., Waldschmidt, T. J., Businga, T. R., Lemish, J. E., Weinstock, J. V., Thorne, P. S., & KRIEG, A. M. (1998) · PubMed · Cited by 546
Self-citationHonda, K., Yanai, H., Mizutani, T., Negishi, H., Shimada, N., Suzuki, N., Ohba, Y., Takaoka, A., Yeh, W.-C., & Taniguchi, T. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0406933101 · Cited by 525
Mansell, A., Smith, R., Doyle, S. L., Gray, P., Fenner, J. E., Crack, P. J., Nicholson, S. E., Hilton, D. J., O'Neill, L. A. J., & Hertzog, P. J. (2006) · Nature Immunology · doi:10.1038/ni1299 · Cited by 514
Vollmer, J., Tluk, S., Schmitz, C., Hamm, S., Jurk, M., Forsbach, A., Akira, S., Kelly, K. M., Reeves, W. H., Bauer, S., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20051696 · Cited by 513
Self-citationToll‐like receptor 9 binds single‐stranded CpG‐DNA in a sequence‐ and pH‐dependent manner
Rutz, M., Metzger, J., Gellert, T., Luppa, P., Lipford, G. B., Wagner, H., & Bauer, S. (2004) · European Journal of Immunology · doi:10.1002/eji.200425218 · Cited by 503
Uematsu, S., Sato, S., Yamamoto, M., Hirotani, T., Kato, H., Takeshita, F., Matsuda, M., Coban, C., Ishii, K. J., Kawai, T., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20042372 · Cited by 488
Human Keratinocytes Express Functional Toll-Like Receptor 3, 4, 5, and 9
Lebre, M. C., van der Aar, A. M. G., van Baarsen, L., van Capel, T. M. M., Schuitemaker, J. H. N., Kapsenberg, M. L., & de Jong, E. C. (2007) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700530 · Cited by 486
Häcker, H., Vabulas, R. M., Takeuchi, O., Hoshino, K., Akira, S., & Wagner, H. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.4.595 · Cited by 468
Ligand-induced conformational changes allosterically activate Toll-like receptor 9
Latz, E., Verma, A., Visintin, A., Gong, M., Sirois, C. M., Klein, D. C. G., Monks, B. G., McKnight, C. J., Lamphier, M. S., Duprex, W. P., et al. (2007) · Nature Immunology · doi:10.1038/ni1479 · Cited by 465
Zimmermann, S., Egeter, O., Hausmann, S., Lipford, G. B., Röcken, M., Wagner, H., & Heeg, K. M. (1998) · PubMed · Cited by 455
Kline, J. N., Waldschmidt, T. J., Businga, T. R., Lemish, J. E., Weinstock, J. V., Thorne, P. S., & Krieg, A. M. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.6.2555 · Cited by 446
Self-citationLipford, G. B., Bauer, M., Blank, C., Reiter, R., Wagner, H., & Heeg, K. (1997) · European Journal of Immunology · doi:10.1002/eji.1830270931 · Cited by 383
The molecular structure of the Toll-like receptor 3 ligand-binding domain
Bell, J. K., Botos, I., Hall, P. R., Askins, J., Shiloach, J., Segal, D. M., & Davies, D. R. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0505077102 · Cited by 380
Krieg, A. M., Love-Homan, L., Yi, A.-K., & Harty, J. T. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.5.2428 · Cited by 379
Self-citationZimmermann, S., Egeter, O., Hausmann, S., Lipford, G. B., Röcken, M., Wagner, H., & Heeg, K. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.8.3627 · Cited by 367
Rumore, P. M., & Steinman, C. R. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114716 · Cited by 361
Toll‐like receptors 7, 8, and 9: linking innate immunity to autoimmunity
Krieg, A. M., & Vollmer, J. (2007) · Immunological Reviews · doi:10.1111/j.1600-065x.2007.00572.x · Cited by 350
Self-citationMillan, C. L. B., Weeratna, R., Krieg, A. M., Siegrist, C.-A., & Davis, H. L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15553 · Cited by 345
Self-citationHuman lung cancer cells express functionally active Toll-like receptor 9
Droemann, D., Albrecht, D., Gerdes, J., Ulmer, A. J., Branscheid, D., Vollmer, E., Dalhoff, K., Zabel, P., & Goldmann, T. (2005) · Respiratory Research · doi:10.1186/1465-9921-6-1 · Cited by 340
Essential Role of MAPK Phosphatase-1 in the Negative Control of Innate Immune Responses
Salojin, K. V., Owusu, I. B., Millerchip, K. A., Potter, M., Platt, K. A., & Oravecz, T. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.3.1899 · Cited by 337
Hartmann, E., Wollenberg, B., Rothenfußer, S., Wagner, M., Wellisch, D., Mack, B., Giese, T., Gires, O., Endres, S., & Hartmann, G. (2003) · PubMed · Cited by 332
COOPER, C. L., DAVIS, H. L., MORRIS, M. L., EFLER, S. M., ADHAMI, M. A., KRIEG, A. M., CAMERON, D. W., & HEATHCOTE, J. (2004) · Journal of Clinical Immunology · doi:10.1007/s10875-004-6244-3 · Cited by 330
Self-citationElkins, K. L., Rhinehart-Jones, T. R., Stibitz, S., Conover, J. S., & Klinman, D. M. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.4.2291 · Cited by 314
CpG DNA, a novel immune enhancer for systemic and mucosal immunization with influenza virus
Moldoveanu, Z., Love-Homan, L., Huang, W. Q., & Krieg, A. M. (1998) · Vaccine · doi:10.1016/s0264-410x(98)80122-9 · Cited by 310
Self-citationValmori, D., Souleimanian, N. E., Tosello, V., Bhardwaj, N., Adams, S., O'Neill, D., Pavlick, A., Escalon, J. B., Cruz, C. M., Angiulli, A., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703395104 · Cited by 299
The DNA Sugar Backbone 2′ Deoxyribose Determines Toll-like Receptor 9 Activation
Haas, T., Metzger, J., Schmitz, F., Heit, A., Müller, T., Latz, E., & Wagner, H. (2008) · Immunity · doi:10.1016/j.immuni.2008.01.013 · Cited by 298
He, B., Qiao, X., & Cerutti, A. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.7.4479 · Cited by 296
CpG directly induces T-bet expression and inhibits IgG1 and IgE switching in B cells
Liu, N., Ohnishi, N., Ni, L., Akira, S., & Bacon, K. B. (2003) · Nature Immunology · doi:10.1038/ni941 · Cited by 293
Mellor, A. L., Baban, B., Chandler, P. R., Manlapat, A., Kahler, D. J., & Munn, D. H. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.9.5601 · Cited by 290
Wille-Reece, U., Flynn, B. J., Loré, K., Koup, R. A., Miles, A. P., Saul, A., Kedl, R. M., Mattapallil, J. J., Weiss, W. R., Roederer, M., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20052433 · Cited by 275
Yang, K., Puel, A., Zhang, S., Eidenschenk, C., Ku, C.-L., Casrouge, A., Picard, C., von Bernuth, H., Senechal, B., Plancoulaine, S., et al. (2005) · Immunity · doi:10.1016/j.immuni.2005.09.016 · Cited by 272
Chaturvedi, A., Dorward, D., & Pierce, S. K. (2008) · Immunity · doi:10.1016/j.immuni.2008.03.019 · Cited by 272
McCluskie, M. J., & Davis, H. L. (1998) · PubMed · Cited by 264
Halperin, S. A., Van Nest, G., Smith, B., Abtahi, S., Whiley, H., & Eiden, J. J. (2003) · Vaccine · doi:10.1016/s0264-410x(03)00045-8 · Cited by 259
Marshall, J. D., Fearon, K., Abbate, C., Subramanian, S., Yee, P., Gregorio, J., Coffman, R. L., & Van Nest, G. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.1202630 · Cited by 259
Yasuda, K., Yu, P., Kirschning, C. J., Schlatter, B., Schmitz, F., Heit, A., Bauer, S., Hochrein, H., & Wagner, H. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.10.6129 · Cited by 255
Recognition of CpG DNA is mediated by signaling pathways dependent on the adaptor protein MyD88
Schnare, M., Holt†, A. C., Takeda, K., Akira, S., & Medzhitov, R. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00700-4 · Cited by 252
Safety and immunogenicity of CPG 7909 injection as an adjuvant to Fluarix influenza vaccine
Cooper, C. L., Davis, H. L., Morris, M. L., Efler, S. M., Krieg, A. M., Li, Y., Laframboise, C., Al Adhami, M. J., Khaliq, Y., Seguin, I., et al. (2004) · Vaccine · doi:10.1016/j.vaccine.2004.01.058 · Cited by 248
Self-citationDalpke, A. H., Opper, S., Zimmermann, S., & Heeg, K. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.12.7082 · Cited by 241
Yi, A.-K., Chang, M., Peckham, D. W., Krieg, A. M., & Ashman, R. F. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.12.5898 · Cited by 241
Self-citationRepetitive Elements in Mammalian Telomeres Suppress Bacterial DNA-Induced Immune Activation
Gursel, I., Gursel, M., Yamada, H., Ishii, K. J., Takeshita, F., & Klinman, D. M. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.3.1393 · Cited by 241
IFN-α Regulates TLR-Dependent Gene Expression of IFN-α, IFN-β, IL-28, and IL-29
Sirén, J., Pirhonen, J., Julkunen, I., & Matikainen, S. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.4.1932 · Cited by 238
McCluskie, M. J., & Davis, H. L. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.9.4463 · Cited by 237
Walker, P. S., Scharton-Kersten, T., Krieg, A. M., Love-Homan, L., Rowton, E. D., Udey, M. C., & Vogel, J. C. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.12.6970 · Cited by 222
Self-citationGallichan, W. S., Woolstencroft, R. N., Guarasci, T., McCluskie, M. J., Davis, H. L., & Rosenthal, K. L. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.5.3451 · Cited by 220
Simons, F. E. R., Shikishima, Y., Van Nest, G., Eiden, J. J., & HayGlass, K. T. (2004) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2004.03.003 · Cited by 204
Franzius, C., Daldrup-Link, H. E., Wagner-Bohn, A., Sciuk, J., Heindel, W. L., Jürgens, H., & Schober, O. (2002) · Annals of Oncology · doi:10.1093/annonc/mdf012 · Cited by 203
Gelman, A. E., LaRosa, D. F., Zhang, J., Walsh, P. T., Choi, Y., Sunyer, J. O., & Turka, L. A. (2006) · Immunity · doi:10.1016/j.immuni.2006.08.023 · Cited by 202
Antitumor applications of stimulating toll-like receptor 9 with CpG oligodeoxynucleotides
Krieg, A. M. (2004) · Current Oncology Reports · doi:10.1007/s11912-004-0019-0 · Cited by 200
Self-citationCooper, C. L., Davis, H. L., Angel, J. B., Morris, M. L., Elfer, S. M., Seguin, I., Krieg, A. M., & Cameron, D. W. (2005) · AIDS · doi:10.1097/01.aids.0000183514.37513.d2 · Cited by 191
Self-citationIRF family proteins and type I interferon induction in dendritic cells
Tailor, P., Tamura, T., & Ozato, K. (2006) · Cell Research · doi:10.1038/sj.cr.7310018 · Cited by 186
Amoura, Z., Piette, J., Chabre, H., Cacoub, P., Papo, T., Wechsler, B., Bach, J., & Koutouzov, S. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780401217 · Cited by 179
The Molecular Basis for the Lack of Immunostimulatory Activity of Vertebrate DNA
Stacey, K. J., Young, G. R., Clark, F., Sester, D. P., Roberts, T. L., Naik, S., Sweet, M. J., & Hume, D. A. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.7.3614 · Cited by 174
Systemic application of CpG‐rich DNA suppresses adaptive T cell immunity via induction of IDO
Wingender, G., Garbi, N., Schumak, B., Jüngerkes, F., Endl, E., von Bubnoff, D., Steitz, J., Striegler, J., Moldenhauer, G., Tüting, T., et al. (2006) · European Journal of Immunology · doi:10.1002/eji.200535602 · Cited by 170
Sparwasser, T., Vabulas, R. M., Villmow, B., Lipford, G. B., & Wagner, H. (2000) · European Journal of Immunology · doi:10.1002/1521-4141(200012)30:12<3591::aid-immu3591>3.0.co;2-j · Cited by 165
Klinman, D. M., Conover, J., & Coban, C. (1999) · Infection and Immunity · doi:10.1128/iai.67.11.5658-5663.1999 · Cited by 163
Tighe, H., Takabayashi, K., Schwartz, D. H., Marsden, R., Beck, L., Corbeil, J., Richman, D. D., Eiden, J., Spiegelberg, H. L., & Raz, E. (2000) · European Journal of Immunology · doi:10.1002/1521-4141(200007)30:7<1939::aid-immu1939>3.0.co;2-# · Cited by 157
McCluskie, M. J., & Davis, H. L. (2000) · Vaccine · doi:10.1016/s0264-410x(00)00208-5 · Cited by 157
Ashkar, A. A., Bauer, S., Mitchell, W. J., Vieira, J., & Rosenthal, K. L. (2003) · Journal of Virology · doi:10.1128/jvi.77.16.8948-8956.2003 · Cited by 155
Friedberg, J. W., Kim, H., McCauley, M., Hessel, E. M., Sims, P. W., Fisher, D. C., Nadler, L. M., Coffman, R. L., & Freedman, A. S. (2004) · Blood · doi:10.1182/blood-2004-06-2156 · Cited by 154
Gramzinski, R. A., Doolan, D. L., Sedegah, M., Davis, H. L., Krieg, A. Μ., & Hoffman, S. L. (2001) · Infection and Immunity · doi:10.1128/iai.69.3.1643-1649.2001 · Cited by 154
Self-citationLink, B. K., Ballas, Z. K., Weisdorf, D. J., Wooldridge, J. E., Bossler, A., Shannon, M., Rasmussen, W. L., Krieg, A. Μ., & Weiner, G. J. (2006) · Journal of Immunotherapy · doi:10.1097/01.cji.0000211304.60126.8f · Cited by 153
Self-citationChemically Modified Oligonucleotides Exhibit Decreased Immune Stimulation in Mice
Henry, S. P., Stecker, K., Brooks, D., Monteith, D., Conklin, B., & Bennett, C. F. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35315-7 · Cited by 152
Appay, V., Jandus, C., Voelter, V., Reynard, S., Coupland, S. E., Rimoldi, D., Líénard, D., Guillaume, P., Krieg, A. Μ., Cerottini, J., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.3.1670 · Cited by 152
Self-citationStunz, L. L., Lenert, P. S., Peckham, D., Yi, A., Haxhinasto, S. A., Chang, M., Krieg, A. Μ., & Ashman, R. F. (2002) · European Journal of Immunology · Cited by 151
Self-citationBerry, L. J., Hickey, D. K., Skelding, K. A., Bao, S., Rendina, A. M., Hansbro, P. M., Gockel, C. M., & Beagley, K. W. (2004) · Infection and Immunity · doi:10.1128/iai.72.2.1019-1028.2004 · Cited by 145
Microbial DNA Induces a Host Defense Reaction of Human Respiratory Epithelial Cells
Platz, J., Beißwenger, C., Dalpke, A. H., Koczulla, R., Pinkenburg, O., Vogelmeier, C. F., & Bals, R. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.2.1219 · Cited by 145
IL-10 regulates plasmacytoid dendritic cell response to CpG-containing immunostimulatory sequences
Duramad, O., Fearon, K. L., Chan, J. H., Kanzler, H., Marshall, J. D., Coffman, R. L., & Barrat, F. J. (2003) · Blood · doi:10.1182/blood-2003-07-2465 · Cited by 141
Pedersen, G., Andresen, L. O., Matthiessen, M. W., Rask-Madsen, J., & Brynskov, J. (2005) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2005.02848.x · Cited by 138
Lipford, G. B., Sparwasser, T. D., Zimmermann, S., Heeg, K. M., & Wagner, H. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.3.1228 · Cited by 138
Role of Natural Interferon-α Producing Cells (Plasmacytoid Dendritic Cells) in Autoimmunity
Rönnblom, L., Eloranta, M., & Alm, G. V. (2003) · Autoimmunity · doi:10.1080/08916930310001602128 · Cited by 137
Weighardt, H., Feterowski, C., Veit, M., Rump, M., Wagner, H., & Holzmann, B. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.8.4537 · Cited by 137
Dong, L., Ito, S., Ishii, K. J., & Klinman, D. M. (2005) · Arthritis & Rheumatism · doi:10.1002/art.20810 · Cited by 134
Weigel, B. J., Rodeberg, D. A., Krieg, A. Μ., & Blazar, B. R. (2003) · PubMed · Cited by 133
Self-citationIshii, K. J., Takeshita, F., Gürsel, İ., Gürsel, M., Conover, J., Nussenzweig, A., & Klinman, D. M. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020773 · Cited by 130
Cornélie, S., Hoebeke, J., Schacht, A., Bertin, B., Vicogne, J., Capron, M., & Riveau, G. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313406200 · Cited by 124
Vabulas, R. M., Pircher, H., Lipford, G. B., Häcker, H., & Wagner, H. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.5.2372 · Cited by 123
Mitogenicity of DNA from different organisms for murine B cells
Sun, S., Beard, C., Jaenisch, R., Jones, P. A., & Sprent, J. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.7.3119 · Cited by 122
Phosphorothioate Backbone Modification Modulates Macrophage Activation by CpG DNA
Sester, D. P., Naik, S. H., Beasley, S. J., et al. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.8.4165 · Cited by 122
Tsujimura, H., Tamura, T., Kong, H. J., Nishiyama, A., Ishii, K. J., Klinman, D. M., & Ozato, K. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.11.6820 · Cited by 121
B-Cell Lymphomas Differ in their Responsiveness to CpG Oligodeoxynucleotides
Jahrsdörfer, B., Mühlenhoff, L., Blackwell, S. E., Wagner, M., Poeck, H., Hartmann, E., Jox, R. J., Giese, T., Emmerich, B., Endres, S., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1890 · Cited by 121
Yasuda, K., Rutz, M., Schlatter, B., Metzger, J., Luppa, P. B., Schmitz, F., Haas, T. L., Heit, A., Bauer, S., & Wagner, H. (2006) · European Journal of Immunology · doi:10.1002/eji.200535210 · Cited by 120
CpG DNA is an effective oral adjuvant to protein antigens in mice
McCluskie, M. J., Weeratna, R. D., Krieg, A. Μ., & Davis, H. L. (2000) · Vaccine · doi:10.1016/s0264-410x(00)00215-2 · Cited by 119
Self-citationDuramad, O., Fearon, K. L., Chang, B., Chan, J. H., Gregorio, J. D., Coffman, R. L., & Barrat, F. J. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.9.5193 · Cited by 116
Immune Recognition of Foreign DNA
Klinman, D. M., Verthelyi, D. I., Takeshita, F., & Ishii, K. J. (1999) · Immunity · doi:10.1016/s1074-7613(00)80087-4 · Cited by 116
McHutchison, J. G., Bacon, B. R., Gordon, S. C., Lawitz, E., Shiffman, M., Afdhal, N. H., Jacobson, I. M., Muir, A. J., Al-Adhami, M., Morris, M. L., et al. (2007) · Hepatology · doi:10.1002/hep.21773 · Cited by 114
CpG Oligodeoxynucleotides Protect Normal and SIV-Infected Macaques from Leishmania Infection
Verthelyi, D. I., Gürsel, M., Kenney, R. T., Lifson, J. D., Liu, S., Mican, J., & Klinman, D. M. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.9.4717 · Cited by 113
Kim, S. K., Ragupathi, G., Musselli, C., et al. (1999) · Vaccine · doi:10.1016/s0264-410x(99)00316-3 · Cited by 112
Lenert, P. S., Stunz, L. L., Yi, A., Krieg, A. Μ., & Ashman, R. F. (2001) · Antisense and Nucleic Acid Drug Development · doi:10.1089/108729001317022241 · Cited by 109
Self-citationSiegrist, C., Pihlgren, M., Tougne, C., Efler, S. M., Morris, M. L., Al-Adhami, M., Cameron, D. W., Cooper, C., Heathcote, J., Davis, H. L., et al. (2004) · Vaccine · doi:10.1016/j.vaccine.2004.07.014 · Cited by 108
Pyles, R. B., Higgins, D., Chalk, C., Zalar, A., Eiden, J., Brown, C., Nest, G. V., & Stanberry, L. R. (2002) · Journal of Virology · doi:10.1128/jvi.76.22.11387-11396.2002 · Cited by 108
Deng, J. C., Moore, T. A., Newstead, M. W., Zeng, X., Krieg, A. Μ., & Standiford, T. J. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.8.5148 · Cited by 104
Self-citationJahrsdörfer, B., Wooldridge, J. E., Blackwell, S. E., Taylor, C. M., Griffith, T. S., Link, B. K., & Weiner, G. J. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0604373 · Cited by 103
Takauji, R., Iho, S., Takatsuka, H., Yamamoto, S., Takahashi, T., Kitagawa, H., Iwasaki, H., Iida, R., Yokochi, T., & Matsuki, T. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.72.5.1011 · Cited by 99
Gary‐Gouy, H., Lebon, P., & Dalloul, A. H. (2002) · Journal of Interferon & Cytokine Research · doi:10.1089/10799900260100132 · Cited by 98
Cellular Immunity in Breast Cancer Patients Completing Taxane Treatment
Carson, W. E., Shapiro, C. L., Crespin, T. R., Thornton, L. M., & Andersen, B. L. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-1016-03 · Cited by 94
CpG Oligodeoxynucleotides Enhance Host Defense during Murine Tuberculosis
Juffermans, N. P., Leemans, J. C., Florquin, S., Verbon, A., Kolk, A. H. J., Speelman, P., van Deventer, S. J. H., & van der Poll, T. (2002) · Infection and Immunity · doi:10.1128/iai.70.1.147-152.2002 · Cited by 93
Takauji, R., Iho, S., Takatsuka, H., Yamamoto, S., Takahashi, T., Kitagawa, H., Iwasaki, H., Iida, R., Yokochi, T., & Matsuki, T. (2002) · PubMed · Cited by 89
Ho, P. P.-K., da Fontoura, P. P., Ruiz, P. J., Steinman, L., & Garren, H. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.9.4920 · Cited by 86
Enhancement of Infectious Disease Vaccines Through TLR9-Dependent Recognition of CpG DNA
McCluskie, M. J., & KRIEG, A. M. (2006) · Springer eBooks · doi:10.1007/3-540-32636-7_6 · Cited by 79
Self-citationNucleosomes in the pathogenesis of systemic lupus erythematosus
Koutouzov, S., Jerônimo, A. L. C., Campos, H., & Amoura, Z. (2004) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2004.04.001 · Cited by 77
Martin, D. A., & Elkon, K. B. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20052228 · Cited by 74
Kwant, A., & Rosenthal, K. L. (2004) · Vaccine · doi:10.1016/j.vaccine.2004.01.059 · Cited by 73
Alignani, D., Maletto, B. A., Liscovsky, M. V., Ropolo, A. S., Morón, G., & Pistoresi-Palencia, M. C. (2005) · Journal of Leukocyte Biology · doi:10.1189/jlb.0604330 · Cited by 73
Recent advances in the development of immunostimulatory oligonucleotides.
Uhlmann, E., & Vollmer, J. (2003) · PubMed · Cited by 71
Self-citationSugai, T., Mori, M., Nakazawa, M., Ichino, M., Naruto, T., Kobayashi, N., Kobayashi, Y., Minami, M., & Yokota, S. (2005) · Vaccine · doi:10.1016/j.vaccine.2004.09.041 · Cited by 71
Eastcott, J. W., Holmberg, C. J., Dewhirst, F. E., Esch, T. R., Smith, D. J., & Taubman, M. A. (2001) · Vaccine · doi:10.1016/s0264-410x(00)00422-9 · Cited by 70
A second binding site for double-stranded RNA in TLR3 and consequences for interferon activation
Pirher, N., Ivičak‐Kocjan, K., Pohar, J., Benčina, M., & Jerala, R. (2008) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1453 · Cited by 70
Suppressive oligonucleotides protect against collagen‐induced arthritis in mice
Li, D., Ito, S., Ishii, K. J., & Klinman, D. M. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20263 · Cited by 67
Xu, H., An, H., Yu, Y., Zhang, M., Qi, R., & Cao, X. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305698200 · Cited by 64
The adjuvant activity of CpG DNA requires T-bet expression in dendritic cells
Lugo‐Villarino, G., Ito, S.-I., Klinman, D. M., & Glimcher, L. H. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506638102 · Cited by 60
Saikh, K. U., Kissner, T. L., Sultana, A., Ruthel, G. T., & Ulrich, R. G. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.12.7426 · Cited by 60
Modulation of CpG Oligodeoxynucleotide-Mediated Immune Stimulation by Locked Nucleic Acid (LNA)
Vollmer, J., Stenvang, J., Uhlmann, E., Schetter, C., Jurk, M., Wader, T., Wüllner, M., & Krieg, A. Μ. (2004) · Oligonucleotides · doi:10.1089/154545704322988021 · Cited by 59
Self-citationDumais, N., Patrick, A., Moss, R. B., Davis, H. L., & Rosenthal, K. L. (2002) · The Journal of Infectious Diseases · doi:10.1086/344232 · Cited by 58
Maletto, B. A., Ropolo, A. S., Morón, V. G., & Pistoresi-Palencia, M. C. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.72.3.447 · Cited by 58
Yeo, S.-J., Gravis, D. P., Yoon, J.-G., & Yi, A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302076200 · Cited by 56
Balsari, A., Tortoreto, M., Besusso, D., Petrangolini, G., Sfondrini, L., Maggi, R., Ménard, S., & Pratesi, G. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2004.01.023 · Cited by 56
Lenert, P. S., Rasmussen, W. L., Ashman, R. F., & Ballas, Z. K. (2003) · DNA and Cell Biology · doi:10.1089/104454903770238094 · Cited by 56
Olbrich, A. R. M., Schimmer, S., Heeg, K. M., Schepers, K., Schumacher, T. N., & Dittmer, U. (2002) · Journal of Virology · doi:10.1128/jvi.76.22.11397-11404.2002 · Cited by 53
Nesburn, A. B., Ramos, T., Zhu, X., Asgarzadeh, H., Nguyen, V., & BenMohamed, L. (2004) · Vaccine · doi:10.1016/j.vaccine.2004.08.019 · Cited by 52
Leukocyte circulation: one-way or round-trip? Lessons from primary immunodeficiency patients
Badolato, R. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.1103529 · Cited by 52
Cho, J. Y., Miller, M., Baek, K. J., Castaneda, D., Nayar, J., Roman, M., Raz, E., & Broide, D. H. (2001) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2001.119918 · Cited by 49
Sequence requirements for oligodeoxyribonucleotide inhibitory activity
Ashman, R. F. (2005) · International Immunology · doi:10.1093/intimm/dxh222 · Cited by 44
CpG DNA functions as an effective adjuvant for the induction of immune responses in aged mice
Manning, B. M., Enioutina, E. Y., Visic, D. M., Knudson, A. D., & Daynes, R. A. (2001) · Experimental Gerontology · doi:10.1016/s0531-5565(01)00157-7 · Cited by 43
Krieg, A. Μ. (2007) · Immunity · doi:10.1016/j.immuni.2007.11.001 · Cited by 40
Self-citationDirecting Autoimmunity to Nucleoprotein Particles
Hardin, J. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030130 · Cited by 39
Lehmann, M. J., & Sczakiel, G. (2004) · Gene Therapy · doi:10.1038/sj.gt.3302428 · Cited by 38
Parameters of CpG oligodeoxynucleotide‐induced protection against intravaginal HSV‐2 challenge
Sajic, D., Ashkar, A. A., Patrick, A., McCluskie, M. J., Davis, H. L., Levine, K. L., Holl, R., & Rosenthal, K. L. (2003) · Journal of Medical Virology · doi:10.1002/jmv.10518 · Cited by 38
Mechanisms of activation of the RAW264.7 macrophage cell line by transfected mammalian DNA
Jiang, W., Reich, C. F., & Pisetsky, D. S. (2004) · Cellular Immunology · doi:10.1016/j.cellimm.2004.06.003 · Cited by 33
Fukuda, K., Watanabe, T., Tokisue, T., Tsujita, T., Nishikawa, S., Hasegawa, T., Seya, T., & Matsumoto, M. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802284200 · Cited by 33
Effect of cytofectins on the immune response of murine macrophages to mammalian DNA
Zhu, F., Reich, C. F., & Pisetsky, D. S. (2003) · Immunology · doi:10.1046/j.1365-2567.2003.01653.x · Cited by 31
Ray, N. B., & Krieg, A. Μ. (2003) · Infection and Immunity · doi:10.1128/iai.71.8.4398-4404.2003 · Cited by 26
Self-citationVollmer, J., Weeratna, R. D., Jurk, M., Davis, H. L., Schetter, C., Wüllner, M., Wader, T., Liu, M., Kritzler, A., & Krieg, A. Μ. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0104034 · Cited by 22
Self-citationAugmenting the Potency of Breast Cancer Vaccines: Combined Modality Immunotherapy
Emens, L. A., Reilly, R. T., & Jaffee, E. M. (2004) · Breast Disease · doi:10.3233/bd-2004-20103 · Cited by 20
Readett, D., Denis, L., Krieg, A. Μ., et al. (2007) · Journal of Thoracic Oncology · doi:10.1097/01.jto.0000283400.75592.3b · Cited by 6
Self-citation
Cited by
Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns
Bachmann, M. F., & Jennings, G. T. (2010) · Nature Reviews Immunology · doi:10.1038/nri2868 · Cited by 2,106
Vaccine adjuvants: mechanisms and platforms
Zhao, T., Cai, Y., Jiang, Y., He, X., Wei, Y., Yu, Y., & Tian, X. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01557-7 · Cited by 1,020
Myeloid-derived suppressor cells as immunosuppressive regulators and therapeutic targets in cancer
Li, K., Shi, H., Zhang, B., Ou, X., Ma, Q., Chen, Y., Shu, P., Li, D., & Wang, Y. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00670-9 · Cited by 988
Compound Copper Chalcogenide Nanocrystals
Coughlan, C., Ibáñez, M., Dobrozhan, O., Singh, A., Cabot, A., & Ryan, K. M. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00376 · Cited by 930
Bode, C., Zhao, G., Steinhagen, F., Kinjo, T., & Klinman, D. M. (2011) · Expert Review of Vaccines · doi:10.1586/erv.10.174 · Cited by 891
Metadata
- Authors
- Vollmer, J., & Krieg, A. M.
- Venue
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Published
- 2009-03
- Volume
- 61
- Issue
- 3
- Pages
- 195-204
- ISSN
- 0169-409X (ISSN-L)
- OpenAlex
- W1984618863
- Cited by
- 585
- References
- 174
- FWCI
- 2.66
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.